Now or Later: Health Impacts of Delaying 1-Dose HPV Vaccine Implementation in a High-Burden Setting
Emily A. Burger(University of Oslo), Jane J. Kim(Boston Medical Center), Marc Brisson(Centre hospitalier universitaire de Québec), Kiesha Prem(National University of Singapore), Stephen Sy(Harvard University), Mary C. Regan, Mark Jit(London School of Hygiene & Tropical Medicine), Jean‐François Laprise(Université Laval)
Cited by 1
Related Papers
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study
|The Lancet Public Health|2020|2.3k
Age-dependent effects in the transmission and control of COVID-19 epidemics
|Nature Medicine|2020|1.9k
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
|The Lancet|2019|1.3k
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
|The Lancet Global Health|2020|1.2k
Projecting social contact matrices in 152 countries using contact surveys and demographic data
|PLoS Computational Biology|2017|1.1k